BMAL1 and hepatocellular carcinoma: Bmal1/Clock-targeted HCC cells displayed a decreased G1 fraction and a concomitant increase in the G2/M fraction relative to cells transduced with a non-targeting control siRNA (Fig. 2 C and D), indicating inhibited cell cycle progression.